Pharmaceuticals, Biotechnology and Life Sciences
Top-line Phase 2b results are expected in 1H 2020 and may support an NDA submission for livoletide ANN ARBOR, Mich.–(BUSINESS…
–Session Will Focus on Diagnosis of Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy– SEATTLE–(BUSINESS WIRE)–Omeros Corporation (Nasdaq: OMER) today announced an upcoming…
BEDFORD, Mass.–(BUSINESS WIRE)–Stoke Therapeutics, Inc. today announced the appointment of Stephen J. Tulipano, CPA, MBA as chief financial officer. Mr.…
DUBLIN–(BUSINESS WIRE)–The “Acne Therapeutics Market- Growth, Trends, and Forecast (2019 – 2024)” report has been added to ResearchAndMarkets.com’s offering. The…
– First Dosing with Norovirus GII.4 Oral Tablet Vaccine Scheduled for Week of March 18 – SOUTH SAN FRANCISCO, Calif.–(BUSINESS…
Company Will Present New Data from the 1,100 Patient Clinical Study, the Children’s Autism Metabolome Project (CAMP) MADISON, Wis.–(BUSINESS WIRE)–NeuroPointDX,…
Vibegron met both co-primary endpoints demonstrating highly significant reduction in daily urge urinary incontinence episodes and micturitions, compared to placebo…
Urges Shareholders to Vote “FOR” the Proposed Transaction on the WHITE Proxy Card NEW YORK–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE: BMY)…
DUBLIN–(BUSINESS WIRE)–The “Acute Myeloid Leukemia Market – Growth, Trends, and Forecast (2019 – 2024)” report has been added to ResearchAndMarkets.com’s…
Support Reinforces Company’s Commitment to Tackling This Deadly Disease SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Veracyte, Inc. (Nasdaq: VCYT), a leading genomics…